FDA
approval
· 2025-02-03
FDA Approved: ARFORMOTEROL TARTRATE INHALATION SOLUTION — Original Application (Aucta Pharmaceuticals, Inc.)
Summary
FDA approved the original application for arformoterol tartrate inhalation solution, a generic inhaled long-acting beta-agonist for maintenance treatment of COP…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ARFORMOTEROL TARTRATE INHALATION SOLUTION (ARFORMOTEROL TARTRATE)